Pharmaxis Inc, Exton, Pa, announced this week that the Centers for Medicare and Medicaid Services (CMS) has assigned a unique, Level II Health Care Common Procedural Coding System (Level II HCPCS), commonly referred to as a J-code, to ARIDOL® (mannitol inhalation powder) Bronchial Challenge Test Kit. The new J-code becomes effective on January 1, 2012.

ARIDOL is the only dry powder bronchial challenge test approved for use in the United States.

Launched in February 2011, ARIDOL is used to asses bronchial hyperresponsiveness in patients 6 years of age and older who do not have clinically apparent asthma. ARIDOL should not be used as a stand-alone test to assess asthma or as a screening test for asthma, but as part of a physician’s overall assessment of asthma.

J-codes are used by providers to bill Medicare Part B, Medicaid, and most private plans for drugs administered in physicians’ offices and hospital outpatient settings.